Esperion to Report Third Quarter 2021 Financial Results November 2, 2021
October 12 2021 - 8:00AM
Esperion (NASDAQ: ESPR), today announced it will report third
quarter 2021 financial results before the open of the U.S.
financial markets on Tuesday, November 2, 2021.
Following the release, company management will host
a webcast and conference call at 8:00 a.m. ET to discuss financial
results and business progress. The call can be accessed by dialing
(877) 831-3840 (domestic) or (253) 237-1184 (international) five
minutes prior to the start of the call and providing the access
code 2646847.
A live audio webcast can be accessed on the
investor and media section of the Esperion website at
investor.esperion.com. Access to the webcast replay will be
available approximately two hours after completion of the call and
will be archived on the Company's website for approximately 90
days.
ESPERION Therapeutics
ESPERION is The Lipid Management Company. Our goal
is lipid management for everybody, that’s why we work hard to make
our medicines easy to get, easy to take and easy to have. We
discover, develop and commercialize innovative medicines and
combinations to lower cholesterol, especially for patients whose
needs aren’t being met by the status quo. Our entrepreneurial team
of industry leaders is inclusive, passionate and resourceful. For
more information, please visit www.esperion.com and follow us on
Twitter at www.twitter.com/EsperionInc.
Investor Contact:Kaitlyn
BroscoEsperioncorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From May 2024 to Jun 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2023 to Jun 2024